Botanix Pharmaceuticals Limited (ASX: BOT)
Australia
· Delayed Price · Currency is AUD 0.470
+0.010 (2.17%)
Jan 21, 2025, 4:10 PM AEST
Botanix Pharmaceuticals Revenue
In the fiscal year ending June 30, 2024, Botanix Pharmaceuticals had annual revenue of 2.07M AUD, down -45.14%. Botanix Pharmaceuticals had revenue of 1.69M in the half year ending June 30, 2024, a decrease of -38.60%.
Revenue
2.07M
Revenue Growth
-45.14%
P/S Ratio
n/a
Revenue / Employee
188.14K
Employees
11
Market Cap
839.79M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 22.18B |
| Pro Medicus | 161.50M |
| Cochlear | 2.24B |
| Sonic Healthcare | 8.97B |
| Telix Pharmaceuticals | 645.68M |
| Ramsay Health Care | 16.66B |
| Ansell | 2.43B |
| Sigma Healthcare | 3.48B |